Abstract Search

ea0022p642 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Echocardiographic assessment of cardiac valves morphology and function in patients with prolactinomas under long-term treatment with cabergoline or bromocriptine

Elenkova Atanaska , Zacharieva Sabina , Shabani Rabhat

Background: Long-term treatment with dopamine agonists (DAs) is considered to be the first-choice therapy for prolactinomas. According to current guidelines DAs can be safely withdrawn in patients with negative pituitary MRI and stable normalization of prolactin levels for at least 3 years. On the other hand, recent studies have shown an increased risk for valvular heart disease in patients with Parkinsons disease treated with high doses of cabergoline. The aim of this s...

0 shares

Endocrine Abstracts

Echocardiographic assessment of cardiac valves morphology and function in patients with prolactinomas under long-term treatment with cabergoline or bromocriptine

BiosciAbstracts